Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

Anavex Life Sciences Corp. AVXL

Full chart Compare
Set alert

Price alert · AVXL

All alert types
1.15 USD -0.07 (-5.74%)

Nov 10, 2026, 11:44 AM EST

1.15 Day range 1.23
1.07 52-week range 7.25
YTD
-67.70%
1 year
-82.28%

Financial health

Altman Z-Score

4.35 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 3

Valuation

P/E -16.5×
FY 2016: -8.6×FY 2017: -12.5×FY 2018: -6.6×FY 2019: -5.9×FY 2020: -10.1×FY 2021: -33.2×FY 2022: -16.6×FY 2023: -10.9×FY 2024: -10.9×FY 2025: -16.5×
FY 2016 5y median -16.5× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 8.0×
FY 2016: 20.2×FY 2017: 7.0×FY 2018: 5.6×FY 2019: 7.6×FY 2020: 9.7×FY 2021: 8.3×FY 2022: 5.6×FY 2023: 3.7×FY 2024: 3.9×FY 2025: 8.0×
FY 2016 5y median 5.6× FY 2025
P/FCF -19.4×
FY 2016: -13.8×FY 2017: -18.8×FY 2018: -9.2×FY 2019: -8.3×FY 2020: -12.4×FY 2021: -41.2×FY 2022: -32.7×FY 2023: -18.8×FY 2024: -15.4×FY 2025: -19.4×
FY 2016 5y median -19.4× FY 2025
EV/EBITDA -14.2×
FY 2016: -7.9×FY 2017: -9.1×FY 2018: -4.8×FY 2019: -4.6×FY 2020: -7.6×FY 2021: -29.2×FY 2022: -13.5×FY 2023: -8.0×FY 2024: -8.0×FY 2025: -14.2×
FY 2016 5y median -13.5× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -5.1%
FY 2016: -7.2%FY 2017: -5.3%FY 2018: -10.9%FY 2019: -12.0%FY 2020: -8.0%FY 2021: -2.4%FY 2022: -3.1%FY 2023: -5.3%FY 2024: -6.5%FY 2025: -5.1%
FY 2016 5y median -5.1% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -48.9%
FY 2016: -233.6%FY 2017: -55.5%FY 2018: -85.2%FY 2019: -129.6%FY 2020: -96.5%FY 2021: -25.1%FY 2022: -33.7%FY 2023: -33.5%FY 2024: -35.8%FY 2025: -48.9%
FY 2016 5y median -33.7% FY 2025
ROIC -54.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -82.0%FY 2021: -27.8%FY 2022: -1.4%FY 2023: -38.4%FY 2024: -44.0%FY 2025: -54.2%
FY 2016 5y median -38.4% FY 2025
ROA -44.7%
FY 2016: -155.1%FY 2017: -48.4%FY 2018: -71.6%FY 2019: -103.8%FY 2020: -76.1%FY 2021: -23.5%FY 2022: -31.4%FY 2023: -30.8%FY 2024: -31.7%FY 2025: -44.7%
FY 2016 5y median -31.4% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 2.8%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -35.1%FY 2022: -21.4%FY 2023: -9.4%FY 2024: 5.2%FY 2025: 2.8%
FY 2016 FY 2025
EPS (diluted) -3.8%
FY 2016: 35.4%FY 2017: 21.4%FY 2018: -18.2%FY 2019: -38.5%FY 2020: 16.7%FY 2021: -20.0%FY 2022: -14.8%FY 2023: 3.2%FY 2024: 13.3%FY 2025: -3.8%
FY 2016 FY 2025
Free Cash Flow -26.7%
FY 2016: -118.5%FY 2017: 2.4%FY 2018: -39.5%FY 2019: -47.2%FY 2020: -14.9%FY 2021: -42.7%FY 2022: 20.2%FY 2023: -14.6%FY 2024: -10.9%FY 2025: -26.7%
FY 2016 FY 2025

Financial Health

Current Ratio 11.6×
FY 2016: 3.0×FY 2017: 7.8×FY 2018: 6.3×FY 2019: 5.0×FY 2020: 4.7×FY 2021: 15.0×FY 2022: 15.0×FY 2023: 12.3×FY 2024: 8.9×FY 2025: 11.6×
FY 2016 5y median 12.3× FY 2025
Quick Ratio 11.6×
FY 2016: 3.0×FY 2017: 7.8×FY 2018: 6.3×FY 2019: 5.6×FY 2020: 4.7×FY 2021: 15.0×FY 2022: 15.0×FY 2023: 12.3×FY 2024: 8.9×FY 2025: 11.6×
FY 2016 5y median 12.3× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 2.2×
FY 2016: 0.6×FY 2017: 1.8×FY 2018: 1.2×FY 2019: 0.8×FY 2020: 0.9×FY 2021: 4.0×FY 2022: 3.1×FY 2023: 3.2×FY 2024: 3.1×FY 2025: 2.2×
FY 2016 5y median 3.1× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -57.8×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-09-30